In 2020, Jian-Ping Wang and Dr. Kendall Lee were among the five projects awarded by the Minnesota Partnership for Biotechnology and Medical Genomics in its 17th year. Their grant, titled “Magnetic Nanodevice Arrays for the Treatment of Neurological Diseases,” will allow them to collaborate over the next two years on an implantable chip array that could potentially help treat a range of conditions including Parkinson’s disease, essential tremor and dystonia, as well as Tourette’s syndrome, obsessive compulsive disorder and depression.
The Minnesota Partnership for Biotechnology and Medical Genomics is a unique collaborative between the Mayo Clinic, University of Minnesota, and State of Minnesota. with the aim of positioning Minnesota as a world leader in biotechnology and medical genomics applications. For the last 18 years, the Partnerships has funded five separate competitive grants that will help partnering researchers advance early studies in medical science impacting conditions that have state-wide impact. Significantly, each awarded project is the collaborative effort of a University of Minnesota and a Mayo Clinic investigator and involves a research inquiry/approach that could not be pursued by either institution independently.